Literature DB >> 23685147

EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma.

Yanfen Ye1, Ying Zhou, Lan Zhang, Yuxiang Chen, Xiaoming Lyu, Longmei Cai, Yaoyong Lu, Yi Deng, Jianguo Wang, Kaitai Yao, Weiyi Fang, Hongbing Cai, Xin Li.   

Abstract

EBV-miR-BART1 has been found to be highly expressed in some cancers including nasopharyngeal carcinoma (NPC), but its exact roles in the pathogenesis of NPC remain unclear. Here, we did RNA deep sequencing to compare the gene expression profile between EBV-miR-BART1-expressing CNE1 cells and the control cells to determine the possible effects of EBV-miR-BART1 in NPC. Gene expression profiling analysis unexpectedly showed a significant number of up- and down-modulated metabolism-associated genes, such as G6PD, SAT1, ASS1, PAST1, FUT1, SGPL1, DHRS3, B4GALT1, PHGDH, IDH2, PISD, UGT8, LDHB and GALNT1, in EBV-miR-BART1-expressing NPC cells, which were next confirmed by RT-qPCR. Moreover, of these metabolism-genes, PSAT1 and PHGDH expression levels were significantly upregulated and most of other genes were obviously up-expressed in NPC specimens compared with chronic nasopharyngitis (CNP) tissues. Collectively, we for the first time found the effects of EBV-miR-BART1 on the expression of mechanism-associated genes in NPC, suggesting a novel role of EBV-miR-BART1 in cancer metabolism, which remains to be fully elucidated.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23685147     DOI: 10.1016/j.bbrc.2013.05.008

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9.

Authors:  Ying Zheng; Zailong Qin; Qiurong Ye; Pan Chen; Zhen Wang; Qun Yan; Zhaohui Luo; Xiaoping Liu; Yanhong Zhou; Wei Xiong; Jian Ma; Guiyuan Li
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

Review 2.  3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.

Authors:  Mingxue Li; Canrong Wu; Yueying Yang; Mengzhu Zheng; Silin Yu; Jinhui Wang; Lixia Chen; Hua Li
Journal:  Cell Oncol (Dordr)       Date:  2021-03-18       Impact factor: 6.730

3.  As Evidence-Based Tumorigenic Role of Epstein-Barr Virus miR-BART1-3p in Neurological Tumors.

Authors:  Mohammad Karimzadeh; Alireza Tabibzadeh; Mohsen Moghoofei; Saeedeh Abbasi; Javid Sadri Nahand; Farzin Sadeghii; Mohammad Hadi Karbalaie Niya; Hossin Keyvani; Farah Bokharaei-Salim; Moein Esghaei; Maryam Esghaei
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

Review 4.  The role of microRNAs in nasopharyngeal carcinoma.

Authors:  Gongjun Tan; Xiaowei Tang; Faqing Tang
Journal:  Tumour Biol       Date:  2014-11-27

5.  Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.

Authors:  Longmei Cai; Yanfen Ye; Qiang Jiang; Yuxiang Chen; Xiaoming Lyu; Jinbang Li; Shuang Wang; Tengfei Liu; Hongbing Cai; Kaitai Yao; Ji-Liang Li; Xin Li
Journal:  Nat Commun       Date:  2015-07-02       Impact factor: 14.919

6.  Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.

Authors:  Longmei Cai; Jinbang Li; Xiaona Zhang; Yaoyong Lu; Jianguo Wang; Xiaoming Lyu; Yuxiang Chen; Jinkun Liu; Hongbing Cai; Ying Wang; Xin Li
Journal:  Oncotarget       Date:  2015-04-10

7.  MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma.

Authors:  Zhanchi Zhang; Jun Ma; Guang Luan; Lin Kang; Yuhong Su; Yanan He; Feng Luan
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

Review 8.  Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients.

Authors:  Yong Shen; Suzhan Zhang; Ren Sun; Tingting Wu; Jing Qian
Journal:  Emerg Microbes Infect       Date:  2015-03-25       Impact factor: 7.163

Review 9.  Phosphoglycerate dehydrogenase: potential therapeutic target and putative metabolic oncogene.

Authors:  Cheryl K Zogg
Journal:  J Oncol       Date:  2014-12-09       Impact factor: 4.375

10.  Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer.

Authors:  Xiao-Qin Jia; Shu Zhang; Hui-Jun Zhu; Wei Wang; Jin-Hong Zhu; Xu-Dong Wang; Jian-Feng Qiang
Journal:  Transl Oncol       Date:  2016-05-10       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.